Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wolf Haldenstein Adler Freeman & Herz LLP is a prominent American law firm specializing in complex class action litigation, including securities, antitrust, and consumer protection. Founded in 1888 and headquartered in New York City, the firm frequently represents institutional and individual investors in legal actions against corporations in the life sciences, biotechnology, and pharmaceutical sectors. Their work often involves investigating potential breaches of fiduciary duty, securities fraud, and issues related to clinical trial disclosures or mergers and acquisitions. While not a healthcare provider or biotech developer, the firm plays a significant role in the legal and regulatory landscape of the healthcare industry by holding companies accountable for corporate governance and transparency. The firm maintains a national presence with multiple offices across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wolf Haldenstein Adler Freeman & Herz.